Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Patient Safety
Patient Safety News
Fidaxomicin Disrupts Clostridium Difficile BiofilmsFidaxomicin, a narrow-spectrum macrocyclic antibiotic, disrupts Clostridium difficile biofilms and kills vegetative cells and spores in vitro, researchers report.
Dapagliflozin: 'Helpful Strategy' for T1D?Research presented at EASD 2017 shows that dapagliflozin may reduce insulin requirements with a low risk of adverse effects in patients with type 1 diabetes.
Medscape Diabetes & Endocrinology, October 20, 2017
